Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes
- PMID: 9339931
- PMCID: PMC1191017
- DOI: 10.1097/00000658-199709000-00004
Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes
Abstract
Objective: The authors reviewed the pathology, complications, and outcomes in a consecutive group of 650 patients undergoing pancreaticoduodenectomy in the 1990s.
Summary background data: Pancreaticoduodenectomy has been used increasingly in recent years to resect a variety of malignant and benign diseases of the pancreas and periampullary region.
Methods: Between January 1990 and July 1996, inclusive, 650 patients underwent pancreaticoduodenal resection at The Johns Hopkins Hospital. Data were recorded prospectively on all patients. All pathology specimens were reviewed and categorized. Statistical analyses were performed using both univariate and multivariate models.
Results: The patients had a mean age of 63 +/- 12.8 years, with 54% male and 91% white. The number of resections per year rose from 60 in 1990 to 161 in 1995. Pathologic examination results showed pancreatic cancer (n = 282; 43%), ampullary cancer (n = 70; 11%), distal common bile duct cancer (n = 65; 10%), duodenal cancer (n = 26; 4%), chronic pancreatitis (n = 71; 11%), neuroendocrine tumor (n = 31; 5%), periampullary adenoma (n = 21; 3%), cystadenocarcinoma (n = 14; 2%), cystadenoma (n = 25; 4%), and other (n = 45; 7%). The surgical procedure involved pylorus preservation in 82%, partial pancreatectomy in 95%, and portal or superior mesenteric venous resection in 4%. Pancreatic-enteric reconstruction, when appropriate, was via pancreaticojejunostomy in 71% and pancreaticogastrostomy in 29%. The median intraoperative blood loss was 625 mL, median units of red cells transfused was zero, and the median operative time was 7 hours. During this period, 190 consecutive pancreaticoduodenectomies were performed without a mortality. Nine deaths occurred in-hospital or within 30 days of operation (1.4% operative mortality). The postoperative complication rate was 41%, with the most common complications being early delayed gastric emptying (19%), pancreatic fistula (14%), and wound infection (10%). Twenty-three patients required reoperation in the immediate postoperative period (3.5%), most commonly for bleeding, abscess, or dehiscence. The median postoperative length of stay was 13 days. A multivariate analysis of the 443 patients with periampullary adenocarcinoma indicated that the most powerful independent predictors favoring long-term survival included a pathologic diagnosis of duodenal adenocarcinoma, tumor diameter <3 cm, negative resection margins, absence of lymph node metastases, well-differentiated histology, and no reoperation.
Conclusions: This single institution, high-volume experience indicates that pancreaticoduodenectomy can be performed safely for a variety of malignant and benign disorders of the pancreas and periampullary region. Overall survival is determined largely by the pathology within the resection specimen.
Similar articles
-
Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.Ann Surg. 2002 Sep;236(3):355-66; discussion 366-8. doi: 10.1097/00000658-200209000-00012. Ann Surg. 2002. PMID: 12192322 Free PMC article. Clinical Trial.
-
Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome.Ann Surg. 1999 May;229(5):613-22; discussion 622-4. doi: 10.1097/00000658-199905000-00003. Ann Surg. 1999. PMID: 10235519 Free PMC article. Clinical Trial.
-
Periampullary adenocarcinoma: analysis of 5-year survivors.Ann Surg. 1998 Jun;227(6):821-31. doi: 10.1097/00000658-199806000-00005. Ann Surg. 1998. PMID: 9637545 Free PMC article.
-
[Complications of two types of pancreatic anastomosis after pancreaticoduodenectomy].Ann Chir. 1996;50(6):431-7. Ann Chir. 1996. PMID: 8991198 Review. French.
-
Reoperative pancreaticoduodenectomy.Ann Surg. 1994 Feb;219(2):211-21. doi: 10.1097/00000658-199402000-00014. Ann Surg. 1994. PMID: 7907464 Free PMC article. Review.
Cited by
-
Defining treatment and outcomes of hepaticojejunostomy failure following pancreaticoduodenectomy.J Gastrointest Surg. 2013 Mar;17(3):451-60. doi: 10.1007/s11605-012-2118-9. Epub 2013 Jan 5. J Gastrointest Surg. 2013. PMID: 23292459
-
External tube pancreatostomy reduces the risk of mortality associated with completion pancreatectomy for symptomatic fistulas complicating pancreaticoduodenectomy.J Gastrointest Surg. 2013 Feb;17(2):332-8. doi: 10.1007/s11605-012-2100-6. Epub 2012 Dec 1. J Gastrointest Surg. 2013. PMID: 23207684
-
Postoperative outcomes following pancreaticoduodenectomy: how should age affect clinical practice?World J Surg Oncol. 2013 Jun 6;11:131. doi: 10.1186/1477-7819-11-131. World J Surg Oncol. 2013. PMID: 23742036 Free PMC article.
-
Evidence-Based Surgical Treatments for Chronic Pancreatitis.Dtsch Arztebl Int. 2016 Jul 25;113(29-30):489-96. doi: 10.3238/arztebl.2016.0489. Dtsch Arztebl Int. 2016. PMID: 27545699 Free PMC article. Review.
-
Management of duodenal adenomatosis in FAP: single centre experience.Fam Cancer. 2012 Jun;11(2):167-73. doi: 10.1007/s10689-011-9496-0. Fam Cancer. 2012. PMID: 22131053 Clinical Trial.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical